| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Chemomab Therapeutics Ltd. | Chief Executive Officer, Director | American Depositary Shares | 2.5K | $12.6K | $5.03 | Mar 14, 2022 | Direct |
| Chemomab Therapeutics Ltd. | Chief Executive Officer, Director | Option to Purchase American Depositary Shares | 459K | Oct 25, 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CMMB | Chemomab Therapeutics Ltd. | Mar 14, 2022 | 3 | $9.94K | 4 | Mar 15, 2022 | Chief Executive Officer, Director |
| CMMB | Chemomab Therapeutics Ltd. | Oct 25, 2021 | 0 | $0 | 3 | Nov 4, 2021 | Chief Executive Officer, Director |